Oslo, 3 November 2025, Notification of trade
Following the completion of the merger between BerGenBio and Oncoinvent as announced on 29 October 2025, merger consideration shares have been delivered to former shareholders of Oncoinvent as of 29 October 2025 (as registered in Euronext Securities Oslo on 31 October 2025). Upon receipt of such merger consideration shares, Geveran Trading Co. Ltd today owns 10,997,008 shares in Oncoinvent ASA ("Oncoinvent"), representing a total of 7.02% of Oncoinvent's issued shares and voting rights (based on 156,641,128 shares issued by Oncoinvent).
This disclosure is made pursuant to section 4-2 of the Norwegian Securities Trading Act and is subject to the disclosure requirement pursuant to section 5-12 of the Norwegian Securities Trading Act.